Seven Springs Wealth Group, LLC Abb Vie Inc. Transaction History

Seven Springs Wealth Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$107.43 - $135.93 $446,264 - $564,653	-4,154 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $393,169 - $438,013	3,737 Added 896.16%	4,154 $468,000
Q1 2021 May 07, 2021	SELL	$102.3 - $112.62 $6,649 - $7,320	-65 Reduced 13.49%	417 $45,000
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $5,231 - $7,063	65 Added 15.59%	482 $52,000
Q4 2019 Feb 21, 2020	BUY	$72.13 - $90.25 $30,078 - $37,634	417 New	417 $37,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Seven Springs Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Springs Wealth Group, LLC with notifications on news.